Routing to Endovascular Treatment of Ischemic Stroke in Korea: Recognition of Need for Process Improvement

J Korean Med Sci. 2020 Oct 26;35(41):e347. doi: 10.3346/jkms.2020.35.e347.

Abstract

Background: To track triage, routing, and treatment status regarding access to endovascular treatment (EVT) after acute ischemic stroke (AIS) at a national level.

Methods: From national stroke audit data, potential candidates for EVT arriving within 6 hours with National Institute of Health Stroke Scale score of ≥ 7 were identified. Acute care hospitals were classified as thrombectomy-capable hospitals (TCHs, ≥ 15 EVT cases/year) or primary stroke hospital (PSH, < 15 cases/year), and patients' initial routes and subsequent inter-hospital transfer were described. Impact of initial routing to TCHs vs. PSHs on EVT and clinical outcomes were analyzed using multilevel generalized mixed effect models.

Results: Out of 14,902 AIS patients, 2,180 (14.6%) were EVT candidates. Eighty-one percent of EVT candidates were transported by ambulance, but only one-third were taken initially to TCHs. Initial routing to TCHs was associated with greater chances of receiving EVT compared to initial routing to PSHs (33.3% vs 12.1%, P < 0.001; adjusted odds ratio [aOR], 2.21; 95% confidence interval [CI], 1.59-2.92) and favorable outcome (38.5% vs. 28.2%, P < 0.001; aOR, 1.52; 95% CI, 1.16-2.00). Inter-hospital transfers to TCHs occurred in 17.4% of those initially routed to a PSH and was associated with the greater chance of EVT compared to remaining at PSHs (34.8% vs. 7.5%, P < 0.001), but not with better outcomes.

Conclusion: Two-thirds of EVT candidates were initially routed to PSHs despite greater chance of receiving EVT and having favorable outcomes if routed to a TCH in Korea. Process improvement is needed to direct appropriate patients to TCHs.

Keywords: Endovascular Treatment; Organization; Stroke; Stroke Center; Transfer.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Endovascular Procedures
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Hospitals
  • Humans
  • Ischemic Stroke / drug therapy
  • Ischemic Stroke / surgery*
  • Male
  • Middle Aged
  • Odds Ratio
  • Patient Transfer
  • Republic of Korea
  • Thrombectomy
  • Treatment Outcome

Substances

  • Fibrinolytic Agents